| Authors: |
Lawrence MN; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tamen RM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Martinez P; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sable-Hunt A; Addario Lung Cancer Medical Institute, San Carlos, California., Addario T; Addario Lung Cancer Medical Institute, San Carlos, California., Barbour P; Addario Lung Cancer Medical Institute, San Carlos, California., Shaffer T; Resolution Bioscience, Kirkland, Washington., Hosseini SA; Resolution Bioscience, Kirkland, Washington., Bertucci C; Resolution Bioscience, Kirkland, Washington., Lim LP; Resolution Bioscience, Kirkland, Washington., Hong F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Michael K; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Simon GR; Department of Thoracic/Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Riess JW; Division of Hematology/Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. |
